
Avatrombopag in Chronic ITP and Post-HSCT Thrombocytopenia
Dr. Chokri Ben Lamine, Adult Hematology and Stem Cell Transplantation Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:
“Avatrombopag – Hema-Fellows Review
(Adult focus
• Chronic ITP/Post-HSCT thrombocytopenia – ASH/NCCN 2024-25)
Overview
•Oral, non-peptide TPO-Receptor Agonist
•Stimulates megakaryocyte proliferation and platelet production
•FDA-approved for:
• Chronic ITP after ≥1 prior therapy
• Thrombocytopenia in chronic liver disease pre-procedure (not hematology use)
•Off-label: persistent thrombocytopenia post-HSCT / chemotherapy-induced
Adult Dosing (Chronic ITP)
•Start: 20 mg PO once daily with food
•Adjust q2 wk to keep Plt ≥50×10⁹/L (avoid >200–250)
• If Plt <50×10⁹/L → ↑ by 20 mg/d (max 40 mg/d)
• If Plt >200–250×10⁹/L → ↓ by 20 mg/d
• If Plt >400×10⁹/L → hold → restart at ↓ dose when <150×10⁹/L
•Do NOT exceed 40 mg/d for ITP
Administration Advantage vs Eltrombopag
•Take with food (↑ absorption)
•No restriction with dairy, calcium, iron, antacids → easier for patients
Monitoring
•CBC weekly ×4 wk → then monthly
•Monitor LFTs periodically (less hepatotoxic than eltrombopag)
•Check for thrombosis risk if Plt >200–250×10⁹/L
Safety
•Common: headache, fatigue, contusion
•Rare: thromboembolic events, hepatotoxicity (lower risk vs eltrombopag)
•Long-term data still maturing → monitor for clonal cytogenetic evolution in AA/post-HSCT settings
Clinical Pearls
•Faster platelet rise than eltrombopag in some ITP studies
•Preferred when GI absorption is concern or patient cannot follow fasting rules
•Used in post-HSCT persistent thrombocytopenia at 20–40 mg/d
•Not a rescue for acute bleeding → needs several days for platelet rise
•Not studied for front-line ITP → used after failure of steroids ± IVIG․”
Stay updated on the latest with Hemostasis Today․
-
Oct 3, 2025, 07:53Pancytopenia in Pregnancy: A Time-Critical Hematological Emergency
-
Oct 2, 2025, 14:12Helen McPherson at ISFP-IFRS 2025: Fibrin Clot Structure and Function Modulation by Targeting Fibrinogen aC Region
-
Oct 2, 2025, 10:48Kanishk Kumar: TFPI Market Size - Advancing Hemostasis and Antithrombotic Therapy
-
Oct 2, 2025, 07:31Non-Invasive Management of Radial Artery Pseudoaneurysm
-
Oct 2, 2025, 07:28Mohamed Gamal: Rethinking The Standard of Care for Deep Vein Thrombosis Management
-
Oct 3, 2025, 14:00Quentin Van Thillo Shares His Latest Article on VWD: Grateful to Have Worked with Cedric Hermans
-
Oct 3, 2025, 13:40Cihan Ay and Colleagues on Thromboembolism and Bleeding in Multiple Myeloma
-
Oct 3, 2025, 13:27Laura Haynes: This Was Such a Fun and Collaborative Project to Be a Part of!
-
Oct 3, 2025, 12:40Christian Pfrepper and Team's Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
-
Oct 3, 2025, 12:00Giuseppe Lippi and Colleagues on the Impact of Hemolysis on Coagulation Testing
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 1, 2025, 15:59Anirban Sen Gupta: Thrilled to share a great collaboration story in Nature Portfolio
-
Oct 3, 2025, 14:48Maha Othman - Elected as the Co-Lead for the Basic and Translational Research Platform at CanVECTOR Research Network
-
Oct 3, 2025, 14:41Maria Elisa Mancuso: A Real Pleasure to Participate in The Policy Roundtable on Future of Haemophilia Care in Egypt
-
Oct 2, 2025, 04:37Louise Bannon: Did You Know that 1 in 4 People Lose Their Lives to Blood Clot-Related Conditions?
-
Oct 1, 2025, 16:35World Thrombosis Day 2025․ 8 Ways to Take Control and Save Lives
-
Oct 1, 2025, 12:30World Stroke Academy "Antithrombotic Therapy for Atherosclerotic Stroke Prevention" Webinar is Now Available to Record